Stress Its no surprise that the many demands of midlife, including job pressures, financial strain, and caring for children and possibly aging parents, can make this a psychologically grueling stretch of time
The bottom line Newer GLP-1-based drugs can lead to powerful benefits for blood sugar, weight, and heart health, but nausea can make treatment unpleasant especially during the first few weeks of treatment or shortly after increasing the dose
Semaglutide, liraglutide, and dulaglutide have demonstrated cardiovascular benefits in clinical trials, with Wegovy (semaglutide 2.4 mg) recently receiving FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and obesity
Obesity, insulin resistance, diabetes and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity and Metabolism)
The results of this study found that GLP-1 receptor agonists are associated with significantly reduced rates of new substance use disorders across every major addictive substance studied, including alcohol and nicotine
This unique mechanism provides enhanced weight loss effects compared to single-receptor medications by targeting multiple metabolic pathways simultaneously
